Trial Profile
Observational, Noninterventional Surveillance Study of Patients With Newly Diagnosed Osteosarcoma
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 23 Jan 2017
Price :
$35
*
At a glance
- Drugs Mifamurtide (Primary)
- Indications Osteosarcoma
- Focus Adverse reactions
- Sponsors Takeda Oncology
- 29 Sep 2015 New trial record